Trial intelligence / Profile preview

ReDuNing granules for influenza (wind-heat pattern) phase II trial

CTR20201903Phase 2Completed

Sponsor
Jiangsu Kanion Pharmaceutical Co., Ltd.
Start
Sep 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Reduning Granules in influenza, sponsored by Jiangsu Kanion Pharmaceutical Co., Ltd.. Started Sep 2020; status: completed.

02

Drugs

Reduning Granules
03

Conditions

influenza

Beyond the preview

Go deeper on CTR20201903.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20201903.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call